In terms of prognosis, higher ROS1 expression has been shown to confer a protective prognostic effect in cases of intrahepatic cholangiocarcinoma and invasive ductal carcinoma of the breast [22, 24]. This evidence concerns the gene ROS1 and intrahepatic cholangiocarcinoma.